Dejerine–Roussy syndrome

From Food & Medicine Encyclopedia


Dejerine–Roussy syndrome
Synonyms Thalamic pain syndrome
Pronounce N/A
Specialty N/A
Symptoms Chronic pain, sensory loss, allodynia, dysesthesia
Complications Depression, anxiety, sleep disturbances
Onset Typically after a stroke affecting the thalamus
Duration Long-term, often chronic
Types N/A
Causes Stroke, thalamic infarction
Risks Hypertension, diabetes mellitus, hyperlipidemia, smoking
Diagnosis Clinical diagnosis, neuroimaging
Differential diagnosis Central post-stroke pain, peripheral neuropathy, complex regional pain syndrome
Prevention N/A
Treatment Pain management, antidepressants, anticonvulsants, physical therapy
Medication N/A
Prognosis Variable, often chronic pain
Frequency Rare
Deaths N/A


Dejerine–Roussy syndrome (also known as thalamic pain syndrome, or central post-stroke pain) is a condition developed after a stroke at the level of the thalamus. The syndrome is named after two French neurologists, Joseph Jules Dejerine and Gustave Roussy, who first described the condition in 1906.

Symptoms[edit]

The main symptom of Dejerine–Roussy syndrome is chronic pain, which can be severe and is often resistant to treatment. The pain is typically on one side of the body and can be described as burning, aching, or pricking. Other symptoms can include sensory loss, hemiparesis (weakness on one side of the body), and hemianesthesia (loss of sensation on one side of the body).

Causes[edit]

Dejerine–Roussy syndrome is caused by a lesion in the thalamus, the part of the brain that relays sensory and motor signals to the cerebral cortex. This can occur as a result of a stroke, brain injury, or brain tumor.

Diagnosis[edit]

Diagnosis of Dejerine–Roussy syndrome is based on the patient's symptoms and medical history. Imaging tests such as MRI or CT scan may be used to confirm the presence of a thalamic lesion.

Treatment[edit]

Treatment for Dejerine–Roussy syndrome is focused on managing the chronic pain. This can include medications such as antidepressants, anticonvulsants, and opioids. In some cases, non-drug treatments such as physical therapy, occupational therapy, and cognitive behavioral therapy may be beneficial.

Prognosis[edit]

The prognosis for Dejerine–Roussy syndrome varies. Some patients may experience a reduction in pain over time, while others may continue to experience chronic pain despite treatment.

See also[edit]

References[edit]

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.